About Event

Welcome to the 2nd Integrin-Targeted Drug Development Summit

This is an exciting opportunity to join 80+ experts and be part of the definitive industry forum for drug developers tackling the issues of safety, selectivity, and specificity in integrin drug development, including Autoimmune, Ophthalmology, and IO perspectives to inform your R&D decisions and leverage the lessons learned over the past 20 years to enhance your bed to bedside progression.

Participate in the 2nd Integrin-Targeted Drug Development Summit to keep up to date with the latest integrin research and:

Navigate the complexity of integrin biology, including signaling, cell adhesion, their role in the immune system, and exploring the function of different integrin subtypes

Benchmark best-in-class mechanism of action for leading candidates including novel agonist mechanisms

Discover the untapped potential of integrins’ disease-modifying potential in ophthalmology, oncology, fibrosis, and immunology

Drive confident translation with accurate and predictive insights from preclinical models and cell-based assays

This cross-disciplinary program featuring keynote talks from clinical decision-makers in large pharma, biotech, and academia, will give insights into the full therapeutic opportunity of integrins.

View our full event guide to see our complete speaker line-up, latest agenda, and attending audience.

Previously Attending Companies Include:

Chronic Hep B - website slide